Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicOTCMKTS:ALQAD
Date5/2003
Raised
Post IPO Valuation

General Information

Offices

NEW YORK, USA
850 THIRD AVENUE
SUITE 1801
NEW YORK, NY, 10022
USA

People

CEO, and Member of the Board of Directors
CEO
Chairman of the Board of Directors
Chief Financial Officer
COO
Chief Financial Officer
VP Operations of AquaMed Technologies
Chief Marketing Officer
Show All People

Funding

TOTAL $40.8M
FUNDING TOTAL $20.5M
Venture Round, 3/2011
$1M
Venture Round, 3/2012
$1.05M
Venture Round, 11/2012
$815k
Venture Round, 7/2013
$3M
Venture Round, 11/2013
$1M
Venture Round, 11/2013
$13.7M
POST IPO FUNDING TOTAL $20.3M
Post IPO Equity, 4/2014
$20.3M

Tags

Alliqua

Headquartered in New York, Alliqua, Inc., (OTCBB:ALQA) is a biomedical company focused on the development, manufacturing and marketing of its own proprietary products, utilizing its existing technology portfolio. The company currently markets its own proprietary brands of wound dressings: SilverSeal® Hydrogel, an antimicrobial dressing; and Hydress® a moist wound dressing. We intend to pursue projects in the fields of active ingredient and transdermal drug delivery, as well as advanced wound care.

Alliqua’s core transdermal delivery technology platform is designed to deliver drugs and other beneficial ingredients through the skin. Transdermal delivery has multiple advantages over conventional oral and injection delivery including: Avoidance of hepatic first pass metabolism causing less stress on the liver; Non-invasive nature; Improved patient compliance; Discontinuation of administration by removal of the system; Lower dosage; No dependence on different metabolic rates of individuals; and No interaction with the gastrointestinal system.

In addition, Alliqua’s patch technology can be utilized for the delivery of many drugs, including various proteins that have, until now, necessitated injections or intravenous infusions.

Alliqua intends to capitalize on its technology’s other intrinsic benefits in various market verticals in the healthcare industry, including: wound healing, medical diagnostics and cosmeceuticals.

Recent Milestones

  • Dollar
    Alliqua received $20.3M in Post IPO Equity funding. (4/15/14)
    Posted 4/15/14 at 7:50pm via citybizlist.com
  • Dollar
    Alliqua received $13.7M in Venture Round funding. (11/26/13)
    Posted 11/26/13 at 4:58am via sec.gov
  • Dollar
    Alliqua received $1M in Venture Round funding. (11/6/13)
    Posted 11/7/13 at 7:31pm via sec.gov
  • Dollar
    Alliqua received $3M in Venture Round funding. (7/7/13)
    Posted 5/27/13 at 10:43pm via marketwatch.com
  • Check
    Alliqua added David Johnson as CEO, and Member of the Board of Directors. (1/1/13)
    Posted 7/9/13 at 4:55am
  • Dollar
    Alliqua received $815k in Venture Round funding. (11/16/12)
    Posted 7/9/13 at 4:57am via sec.gov
  • Check
    Alliqua added Ken Londoner as Member, Board of Directors and Chairman, Nominating Committee. (5/1/12)
    Posted 12/15/13 at 9:28am
  • Dollar
    Alliqua received $1.05M in Venture Round funding. (3/1/12)
    Posted 8/30/13 at 4:01am via sec.gov
  • Dollar
    Alliqua received $1M in Venture Round funding. (3/17/11)
    Posted 11/20/13 at 1:43am via sec.gov
  • Stock
    Went public with stock symbol OTCMKTS:ALQAD. (5/23/03)
    Posted 7/8/13 at 4:36am
  • Check
    Alliqua added Gregory Robb as VP Operations of AquaMed Technologies.
    Posted 12/15/13 at 9:27am
  • Check
    Alliqua added Jeffrey Sklar as Member, Board of Directors and Chairman, Compensation Committee.
    Posted 12/15/13 at 9:29am
  • Check
    Alliqua added Joseph M. Leone as Member, Board of Directors – Audit Committee chairman and Nominating Committee.
    Posted 12/15/13 at 9:27am
  • Check
    Alliqua added Perry Karsen as Member, Board of Directors.
    Posted 12/15/13 at 9:27am
  • Check
    Alliqua added Jerome Zeldis as Chairman of the Board of Directors.
    Posted 12/15/13 at 9:27am
  • Check
    Alliqua added Kenneth Pearsen as Member, Board of Directors – Nominating Committee.
    Posted 12/15/13 at 9:28am

Videos

Screenshots

Alliqua screenshot
Above: Homepage
Uploaded: 5/28/13

Stock Price

Sources

  1. SEC (sec.gov) [edit]
  2. SEC (sec.gov) [edit]
  3. SEC (sec.gov) [edit]
  4. Alliqua Raises $3 Million in 2nd Quarter of 2013, Led by Members of Management and its Board of Directors (marketwatch.com) [edit]
  5. SEC (sec.gov) [edit]
  6. SEC (sec.gov) [edit]
  7. Alliqua Raises $20.3 Million in Private Placement (philadelphia.citybizlist.com) [edit]
Edit This Page
Last Edited 4/15/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy